JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 1 filers reported holding JANUX THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,000 | +61.9% | 3,397 | +90.5% | 0.00% | – |
| Q2 2023 | $21,000 | +75.0% | 1,783 | +85.7% | 0.00% | – |
| Q1 2023 | $12,000 | -57.1% | 960 | -56.0% | 0.00% | – |
| Q4 2022 | $28,000 | +833.3% | 2,181 | +832.1% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 234 | +141.2% | 0.00% | – |
| Q2 2022 | $1,000 | -93.8% | 97 | -91.1% | 0.00% | – |
| Q1 2022 | $16,000 | -72.4% | 1,092 | -63.0% | 0.00% | – |
| Q4 2021 | $58,000 | -4.9% | 2,952 | +4.1% | 0.00% | – |
| Q3 2021 | $61,000 | +90.6% | 2,837 | +118.2% | 0.00% | – |
| Q2 2021 | $32,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |